169 related articles for article (PubMed ID: 6099377)
1. Cushing's disease: clinical and laboratory response to bromocriptine therapy.
de Pinho MO; Antunes RC; Lima MB; Francalanci CC; Franco S
J Endocrinol Invest; 1984 Dec; 7(6):585-8. PubMed ID: 6099377
[TBL] [Abstract][Full Text] [Related]
2. Cortisol-suppressible dexamethasone-nonsuppressible cyclic Cushing's disease with evidence of clinical and biochemical remission with bromocriptine.
Mercado-Asis LB; Murayama M; Yamakita N; Morita H; Mune T; Yasuda K; Miura K
Endocrinol Jpn; 1991 Jun; 38(3):315-24. PubMed ID: 1665413
[TBL] [Abstract][Full Text] [Related]
3. ACTH and cortisol response to bromocriptine, and results of long-term therapy, in Cushing's disease.
Kennedy AL; Sheridan B; Montgomery DA
Acta Endocrinol (Copenh); 1978 Nov; 89(3):461-8. PubMed ID: 212917
[TBL] [Abstract][Full Text] [Related]
4. Use of ketoconazole in the treatment of Cushing's syndrome.
Loli P; Berselli ME; Tagliaferri M
J Clin Endocrinol Metab; 1986 Dec; 63(6):1365-71. PubMed ID: 3023421
[TBL] [Abstract][Full Text] [Related]
5. Periodic remission in Cushing's disease with paradoxical dexamethasone response: an expression of periodic hormonogenesis.
Liberman B; Wajchenberg BL; Tambascia MA; Mesquita CH
J Clin Endocrinol Metab; 1976 Oct; 43(4):913-8. PubMed ID: 185234
[TBL] [Abstract][Full Text] [Related]
6. Six year remission of ACTH-dependent Cushing's syndrome using bromocriptine.
Atkinson AB; Kennedy AL; Sheridan B
Postgrad Med J; 1985 Mar; 61(713):239-42. PubMed ID: 2984649
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of high daily dose bromocriptine treatment in Cushing's disease.
Mercado-Asis LB; Yasuda K; Murayama M; Mune T; Morita H; Miura K
Endocrinol Jpn; 1992 Aug; 39(4):385-95. PubMed ID: 1332855
[TBL] [Abstract][Full Text] [Related]
8. [Investigation of Cushing's syndrome. The diagnostic value of the dexamethasone suppression test, the metopirone test and the CRF test].
Johannesen O; Jørgensen H; Frey H; Norman N
Tidsskr Nor Laegeforen; 1989 Sep; 109(26):2678-82. PubMed ID: 2554527
[TBL] [Abstract][Full Text] [Related]
9. Cyclic Cushing's disease in long-term remission with a daily low dose of bromocriptine.
Adachi M; Takayanagi R; Yanase T; Sakai Y; Ikuyama S; Nakagaki H; Osamura Y; Sanno N; Nawata H
Intern Med; 1996 Mar; 35(3):207-11. PubMed ID: 8785455
[TBL] [Abstract][Full Text] [Related]
10. Cushing's syndrome in childhood.
Killinger DW; Hudson RW; Volpé R
Can Med Assoc J; 1972 Jan; 106(2):131-5. PubMed ID: 5058886
[TBL] [Abstract][Full Text] [Related]
11. Concomitant falls of plasma cortisol and ACTH levels in a case of Cushing's disease during treatment with trilostane.
Nomura K; Demura H; Imaki T; Miyagawa M; Ono M; Yano T; Shizume K
Acta Endocrinol (Copenh); 1984 Jan; 105(1):93-8. PubMed ID: 6320567
[TBL] [Abstract][Full Text] [Related]
12. A case of Cushing's disease successfully treated with bromocriptine.
Sumiya N; Hiramatsu K; Arimori S
Jpn J Med; 1990; 29(2):185-90. PubMed ID: 2172607
[TBL] [Abstract][Full Text] [Related]
13. [Effect of cyproheptadine on plasma ACTH and cortisol secretion in a patient with Cushing's disease].
Esposito V; D'Alessandro B; Bellastella A; Iacono G; Bizzarro A; Officioso A; Piccolo C
Boll Soc Ital Biol Sper; 1976 Nov; 52(22):1901-5. PubMed ID: 194608
[No Abstract] [Full Text] [Related]
14. An unusual profile of endocrine study in a patient with pre-Cushing's syndrome.
Kodama C; Nakada T; Sasagawa I; Ishigooka M; Yamaguchi T; Suzuki H
Int Urol Nephrol; 1993; 25(6):517-24. PubMed ID: 8175270
[TBL] [Abstract][Full Text] [Related]
15. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
[TBL] [Abstract][Full Text] [Related]
16. Lack of effect of bromocriptine on ACTH levels in patients with bilateral adrenalectomy for pituitary-dependent Cushing's syndrome.
O'Mullane N; Walker B; Jefferson J; Hipkin L; Diver M; Davis C
J Endocrinol Invest; 1978 Oct; 1(4):355-7. PubMed ID: 229153
[TBL] [Abstract][Full Text] [Related]
17. Long term bromocriptine therapy in Cushing's disease.
Kapcala LP; Jackson IM
J Endocrinol Invest; 1982; 5(2):117-20. PubMed ID: 6284830
[TBL] [Abstract][Full Text] [Related]
18. Effect of bromocriptine in pituitary-dependent Cushing's syndrome.
Boscaro M; Benato M; Mantero F
Clin Endocrinol (Oxf); 1983 Oct; 19(4):485-91. PubMed ID: 6313262
[TBL] [Abstract][Full Text] [Related]
19. Bromocriptine for Cushing's disease.
Kennedy AL; Montgomery DA
Br Med J; 1977 Apr; 1(6068):1083-4. PubMed ID: 192411
[No Abstract] [Full Text] [Related]
20. [Unique type of Cushing's disease in clinical profile: cyclic Cushing's syndrome and Cushing's disease with favorable outcome to a high daily dose of bromocriptine].
Yasuda K; Miura K
Nihon Naibunpi Gakkai Zasshi; 1994 Jan; 70(1):11-6. PubMed ID: 7958078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
